Abstract
A large number of small renal masses (SRMs) with size less than 4 cm are being identified due to advances in diagnostic imaging. As the natural history of these tumours remains unknown, there is no reliable way to predict their behaviour or future growth. Although, partial nephrectomy is the gold standard for treatment of these tumours, ablative non-surgical therapies such as cryoablation and radiofrequency ablation provide a less invasive option of treatment with comparable oncological outcomes. In this systematic review, the principle, indications, methods of treatment, oncological control, complication and renal function of ablative therapies are critically reviewed. Cryotherapy utilizes the principle of inducing tissue destruction by freezing and thawing using argon and helium gasses, respectively. Radiofrequency ablation (RFA) works on the principle of tissue heating. Ablative treatments are particularly useful in the elderly patients, those with comorbidities or in patients with SRMs in solitary kidneys or renal impairment. Ablative therapies have less procedure-related complications and have promising medium-term oncological outcome. Longer-term results are accumulating. Cryotherapy may be a better modality for oncological control than RFA. Ablative therapy has emerged as a viable treatment options for SRMs with recurrence free survival rates approaching that of extirpative surgery. However, there is no consensus in the literature on the best selection criteria and this needs further refinement. Prospective long-term data with regards to oncological control is still needed
Similar content being viewed by others
References
Chow WH, Devesa SS, Warren JL, Fraumeni JF (1999) Rising incidence of renal cell cancer in the United States. JAMA 281(17):1628–1631
Crispen PL, Uzzo RG (2007) The natural history of untreated renal masses. BJU Int 99(5 Pt B):1203–1207. doi:10.1111/j.1464-410X.2007.06811.x
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DYT, Uzzo RG (2006) The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 175(2):425–431. doi:10.1016/S0022-5347(05)00148-5
Lee CT, Katz J, Shi W, Thaler HT, Reuter VE, Russo P (2000) Surgical management of renal tumors 4 cm. Or less in a contemporary cohort. J Urol 163(3):730–736
Lau WK, Blute ML, Weaver AL, Torres VE, Zincke H (2000) Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc 75(12):1236–1242
McKiernan J, Simmons R, Katz J, Russo P (2002) Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59(6):816–820
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178(1):41–46
Hadjipavlou M, Khan F, Fowler S, Joyce A, Keeley FX, Sriprasad S (2016) Partial vs radical nephrectomy for T1 renal tumours: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. BJU Int 117(1):62–71
Gill IS (2003) Minimally invasive nephron-sparing surgery. Urologic Clin North Am 30(3):551–579
Zargar H, Atwell TD, Cadeddu JA, Jean J, Janetschek G, Kaouk JH, Matin SF, Polascik TJ, Zargar-Shoshtari K, Thompson RH (2016) Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol 69(1):116–128
Khan F, Sriprasad S, Keeley FX (2012) Cryosurgical ablation for small renal masses, current status and future prospects. Brit J Med Surg Urol 5:S28–S34
Sriprasad S. and Marsh H. (2011). The management of small renal tumours by ablative therapies. INTECH Open Access Publisher
Rewcastle JC, Sandison GA, Saliken JC, Donnelly BJ, McKinnon JG (1999) Considerations during clinical operation of two commercially available cryomachines. J Surg Oncol 71(2):106–111
Acker JP, Larese A, Yang H, Petrenko A, McGann LE (1999) Intracellular ice formation is affected by cell interactions. Cryobiology 38(4):363–371. doi:10.1006/cryo.1999.2179
Bischof JC, Smith D, Pazhayannur PV, Manivel C, Hulbert J, Roberts KP (1997) Cryosurgery of dunning AT-1 rat prostate tumor: thermal, biophysical, and viability response at the cellular and tissue level. Cryobiology 34(1):42–69. doi:10.1006/cryo.1996.1978
Daum PS, Bowers WD, Tejada J, Hamlet MP (1987) Vascular casts demonstrate microcirculatory insufficiency in acute frostbite. Cryobiology 24(1):65–73
Clarke DM, Robilotto AT, Rhee E, VanBuskirk RG, Baust JG, Gage AA, Baust JM (2007) Cryoablation of renal cancer: variables involved in freezing-induced cell death. Technol Cancer Res Treat 6(2):69–79
Janzen N, Zisman A, Pantuck AJ, Perry K, Schulam P, Belldegrun AS (2002) Minimally invasive ablative approaches in the treatment of renal cell carcinoma. Current Urol Rep 3(1):13–20
Chodez M, Fiard G, Arnoux V, Descotes J-L, Long J-A (2015) Ablative treatments in localised renal cancer: literature review in 2014. Progrès en urologie : journal de l’Association française d'urologie et de la Société française d'urologie 25(9):499–509
Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113(10):2671–2680. doi:10.1002/cncr.23896
Autorino R, Haber G-P, White MA, Stein RJ, Kaouk JH (2010) New developments in renal focal therapy. J Endourol/Endourological Soc 24(5):665–672. doi:10.1089/end.2009.0643
Laguna MP, Beemster P, Kumar V, Kumar P, Klingler HC, Wyler S, de la Rosette JJ (2009) Perioperative morbidity of laparoscopic cryoablation of small renal masses with ultrathin probes: a European multicentre experience. Eur Urol 56(2):355–361
Lokken RP, Gervais DA, Arellano RS, Tuncali K, Morrison PR, Tatli S et al (2007) Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. AJR Am J Roentgenol 189(4):845–848. doi:10.2214/AJR.07.2015
Nielsen TK, Lagerveld BW, Keeley F, Lughezzani G, Sriprasad S, Barber NJ, Hansen LU, Larcher A, Guazzoni G, Van Der Zee JA, Ismail M (2016) 1094 outcomes after laparoscopic assisted renal cryoablation: a retrospective EuRECA multinational analysis. Eur Urol Suppl 3(15):e1094–e1094a
Sisul DM, Liss MA, Palazzi KL, Briles K, Mehrazin R, Gold RE, Masterson JH, Mirheydar HS, Jabaji R, Stroup SP, James OL (2013) RENAL nephrometry score is associated with complications after renal cryoablation: a multicenter analysis. Urology 81(4):775–780
Beemster P, Phoa S, Wijkstra H, de la Rosette J, Laguna P (2008) Follow-up of renal masses after cryosurgery using computed tomography; enhancement patterns and cryolesion size. BJU Int 101(10):1237–1242. doi:10.1111/j.1464-410X.2007.07437.x
Berger A, Kamoi K, Gill IS, Aron M (2009) Cryoablation for renal tumors: current status. Curr Opin Urol 19(2):138–142. doi:10.1097/MOU.0b013e328323f618
Johnson S, Pham KN, See W, Begun FP, Langenstroer P (2014) Laparoscopic cryoablation for clinical stage T1 renal masses: long-term oncologic outcomes at the Medical College of Wisconsin. Urology 84(3):613–618. doi:10.1016/j.urology.2014.03.055
Kunkle DA, Egleston BL, Uzzo RG (2008) Excise, ablate or observe: the small renal mass dilemma—a meta-analysis and review. J Urol 179(4):1227–1233 . doi:10.1016/j.juro.2007.11.047discussion 1233–4
Woldu SL, Thoreson GR, Okhunov Z, Ghandour R, Rothberg MB, RoyChoudhury A et al (2015) Comparison of renal parenchymal volume preservation between partial nephrectomy, cryoablation, and radiofrequency ablation using 3D volume measurements. J Endourol/ Endourological Soc 29(8):948–955. doi:10.1089/end.2014.0866
Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA (2002) Incomplete renal tumor destruction using radio frequency interstitial ablation. J Urol 168(6):2406–2409 . doi:10.1097/01.ju.0000037915.89846.b6discussion 2409–10
Altunrende F, Autorino R, Hillyer S, Yang B, Laydner H, White MA et al (2011) Image guided percutaneous probe ablation for renal tumors in 65 solitary kidneys: functional and oncological outcomes. J Urol 186(1):35–41. doi:10.1016/j.juro.2011.03.024
Khan F, Mahmalji W, Madaan S, Dickinson IK, Keeley FX, Lagerveld BW, Sriprasad S, (2013). Multi-institutional analysis of renal function following cryoablation of small renal masses in solitary kidneys. In BJU INTERNATIONAL (Vol. 111, pp. 37–37). 111
Weight CJ, Fergany AF, Gunn PW, Lane BR, Novick AC (2008) The impact of minimally invasive techniques on open partial nephrectomy: a 10-year single institutional experience. J Urol 180(1):84–88. doi:10.1016/j.juro.2008.03.049
Ramirez D, Ma YB, Bedir S, Antonelli JA, Cadeddu JA, Gahan JC (2014) Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes. J Endourol 28(3):330–334
Levinson AW, Su L-M, Agarwal D, Sroka M, Jarrett TW, Kavoussi LR, Solomon SB (2008) Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 180(2):499–504 . doi:10.1016/j.juro.2008.04.031discussion 504
Stern JM, Svatek R, Park S, Hermann M, Lotan Y, Sagalowsky AI, Cadeddu JA (2007) Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 100(2):287–290. doi:10.1111/j.1464-410X.2007.06937.x
Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA (2010) Durable oncologic outcomes after radiofrequency ablation. Cancer 116(13):3135–3142
Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63(3):486–492
Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67(2):252–259. doi:10.1016/j.eururo.2014.07.021
Kutikov A, Smaldone MC, Uzzo RG (2015) Focal therapy for treatment of the small renal mass: dealer’s choice or a therapeutic gamble? Eur Urol 67(2):260–261. doi:10.1016/j.eururo.2014.08.034
Marberger M, Schatzl G, Cranston D, Kennedy JE (2005) Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 95(Suppl 2):52–55. doi:10.1111/j.1464-410X.2005.05200.x
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrag, K., Sriprasad, S. Non-Surgical Ablative Therapy for Management of Small Renal Masses—Current Status and Future Trends. Indian J Surg Oncol 8, 39–45 (2017). https://doi.org/10.1007/s13193-016-0598-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-016-0598-x